India to Australia: Calcium Export Trade Route
India has recorded 401 verified shipments of Calcium exported to Australia, representing a combined trade value of $7.6M USD. This corridor is served by 23 active Indian exporters, with an average shipment value of $19.0K USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED, which accounts for 73% of total export value with 251 shipments worth $5.6M USD. On the buying side, SUN PHARMA ANZ PTY LIMITED is the largest importer in Australia with $2.6M USD in purchases. The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, CIPLA LIMITED, K PATEL PHYTO EXTRACTIONS PRIVATE LIMITED — together control 88% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Australia Calcium corridor is one of India's established pharmaceutical export routes, with 401 shipments documented worth a combined $7.6M USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 73% of all export value, reflecting the consolidated nature of India's calcium manufacturing sector.
Across 23 active suppliers, the average shipment value stands at $19.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with calcium's non-urgent bulk-order profile.
Shipment activity peaks during April-June, with an average transit time of 14 days port-to-port. The route has recorded an annual growth rate of 28.2%, placing it at rank #5 among India's top calcium export destinations globally.
On the import side, key buyers of Indian calcium in Australia include SUN PHARMA ANZ PTY LIMITED, SUN PHARMA ANZ PTY LTD., SUN PHARMA ANZ PTY LTD and 38 others. SUN PHARMA ANZ PTY LIMITED is the single largest importer with 98 shipments valued at $2.6M USD.
